ticker,entry_zone_low,entry_zone_high,next_earnings,risk_level,notes
INOD,TBD,TBD,TBD,medium,‚≠ê TOP PICK - Only 2 analysts 79% revenue growth PROFITABLE - Run /deep-stock-research INOD first
ASYS,TBD,TBD,TBD,medium,Zacks #1 Strong Buy - AI chip equipment 5x growth - Small cap $100-200M
PD,TBD,TBD,TBD,medium,DevOps + AI automation - Down 45% from highs value opportunity - Research needed
RXRX,TBD,TBD,TBD,high,AI drug discovery biotech - HIGH RISK 1% max position - Clinical trial dependent
